CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenue, net	$ 1,673,998	$ 225,412	$ 4,166,754	$ 526,032
Cost of revenues	(1,645,781)	(90,477)	(2,662,476)	(374,430)
Gross profit	28,217	134,934	1,504,278	151,602
Income from grants	507,606	16,076	631,787	159,182
Research and development expenses	(893,215)	(37,640)	(1,561,049)	(81,273)
Administrative and selling expenses	(13,040,649)	(886,629)	(27,558,242)	(1,641,063)
Amortization of intangibles	(309,734)	0	(467,447)	0
Operating loss	(13,707,773)	(773,258)	(27,450,673)	(1,411,552)
Finance costs	(13,542)	(1,712)	(26,961)	(4,749)
Fair value change of warrant liability	2,421,874	0	15,833,334	0
Foreign exchange differences, net	(15,256)	(8,005)	(2,141)	(26,584)
Other (expenses) / income, net	(15,960)	31,058	78,146	24,848
Loss before income tax	(11,330,657)	(751,917)	(11,568,295)	(1,418,037)
Income tax	50,935	3,101	50,935	0
Net loss	$ (11,279,722)	$ (748,816)	$ (11,517,360)	$ (1,418,037)
Net loss per share
Basic loss per share (in dollars per share)	$ (0.23)	$ (0.03)	$ (0.26)	$ (0.07)
Basic weighted average number of shares (in shares)	48,325,164	23,182,817	43,982,039	21,180,639
Diluted loss per share (in dollars per share)	$ (0.23)	$ (0.03)	$ (0.26)	$ (0.07)
Diluted weighted average number of shares (in shares)	48,325,164	23,182,817	43,982,039	21,180,639